
Medical tourism : Medium term trend

BE FINANCIALLY INDEPENDENT






















The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
Vijay Diagnostic Center IPO-Established in 1981, Vijaya Diagnostic Centre is one of the fastest-growing diagnostic chains in Southern India
Business — The company offers a one-stop solution for pathology and radiology testing services. The company offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers.
Region of operation — Company’s operational network consists of 80 diagnostic centers and 11 reference laboratories spread across 13 cities and towns in the states of Telangana, Andhra Pradesh, National Capital Region, and Kolkata. 96.2% of the revenue comes from Hyderabad, the rest of Telangana, and the Andhra Pradesh region.
Offer purpose —
The IPO is entirely an offer for sale to provide partial exit to existing investors, who will be divesting 30 per cent of the stake
while the promoter is divesting 5 per cent.
Risks —
Company is in a highly competitive space
High regional concentration risk
Company not getting any proceeds from IPO for growth
Strength —
Largest and fastest-growing diagnostic chain in Southern India.
Affordable diagnostics service provider with a focus on superior quality.
Strong technical capabilities, cutting-edge diagnostic testing technology and robust IT infrastructure.
High brand recalls driving high individual consumer business.
Future
Company is operating with non-franchise model so growth is based on company reach. Focus is more on quality which bring people back to same place. Although the industry is highly competitive, but regional it has strong presence.
Valuations
Valuations are slightly lower considering peers but look reasonable
If we see growth projections, then valuations are at par or premium only
Should we apply?
We can completely avoid
Wait for lower prices to emerge to invest
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.
The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
Clean Science and technology IPO– Incorporated in the year 2003, fine and specialty chemical manufacturing company, with innovative chemical processes developed in-house. Clean Science and Technology is a family-owned business and work primarily on developing clean and eco-friendly manufacturing processes.
Business — Clean Science Technology manufactures functionally critical specialty chemicals such as performance chemicals, pharmaceutical intermediates and FMCG chemicals. Its products are used as key starting level materials, as inhibitors, or as additives, by customers, for products
Region of operation — Customers include manufacturers and distributors in India as well as other international markets including China,
Europe, the US, Taiwan, Korea, and Japan. Approx. 66% of the company’s revenues come from exports
Offer purpose — The IPO is 100% Offer For Sale (OFS) . None of the proceeds will flow to the company
Risks —
Company will not get anything from IPO for future expansion etc
Highly competitive industry and well established peers
High dependence on exports
Strength
Globally leading supplier of certain chemicals; Ansole, 4-MAP, MEHQ, BHA, DCC, etc.
Strategically located manufacturing facility with close proximity to JNPT port to export products.
Strong long-term relationship with key customers.
Consistent track record of financial performance.
International presence with export to several countries i.e. China, USA, Korea, Japan, Taiwan, etc.
Future
Company has been growing well and automated operations, continued focus on product identification, process innovation, catalyst development, significant scale of operations as well as our measures towards strategic backward integration have all contributed to its success as one of the fastest growing and among the most profitable specialty chemical companies globally .
Valuations
Valuations are little on higher side and compare well with peers
Should we apply?
People can subscribe for long term and keep on adding on dips & review holdings with each quarter earnings
Also Read
Burger King IPO crisp Summary — Listing with huge gains as shared
CAMS IPO crisp summary — Listed with 20% gains as shared
Happiest Minds IPO crisp summary –Listed with substantial gains as shared
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.
The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
KIMS IPO– Incorporated in the year 1973, KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered.
Business — The Hyderabad-based hospital chain offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities, and an additional quaternary healthcare facility in tier-1 cities.
Region of operation –Main presence in 2 states , Telagana and Andhra Pradesh
Offer purpose — The IPO includes a fresh issue of Rs 200 cr and an Offer For Sale (OFS) of up to 2.35 cr equity shares by the promoters and existing shareholders. This includes roughly 1.6 cr shares by the biggest investor in the company – General Atlantic Singapore KH Pte. for prepayment of borrowings and general purposes
Risks —
Extremely high level of dependency on top 10 doctors
Concentrated region of operation
ARPOB is on the lower side as compared to industry numbers
Strength
Multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities at afforable rates
Better cost operating profile wrt peers due to operational leverage
Strong Balance sheet and operating margins
KIMS has expanded its business by successfully completing 4 significant acquisitions from FY 2017-2018 to FY 2019-2020
Future
Company has plans to expand number of beds and expanding in Chennai and Bengaluru in coming years that will help the growth
As hospital chain becomes more mature, EBITDA margin will improve further
Valuations
Valuations are reasonable and compare well with peers

Should we apply?
People can subscribe for long term and keep on adding on dips & review holdings with each quarter earnings
Also Read
Burger King IPO crisp Summary — Listing with huge gains as shared
CAMS IPO crisp summary — Listed with 20% gains as shared
Happiest Minds IPO crisp summary –Listed with substantial gains as shared
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.


